V
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K22.4 KBVICURON PHARMACEUTICALS INCSep 12, 12:58 PM ET·0001193125-05-183717
- 8-K96.6 KBVICURON PHARMACEUTICALS INCAug 8, 1:51 PM ET·0001193125-05-160464
- 10-Q488.4 KBVICURON PHARMACEUTICALS INCAug 5, 1:36 PM ET·0001193125-05-158885
- 8-K30.0 KBVICURON PHARMACEUTICALS INCJun 23, 5:10 PM ET·0001193125-05-130069
- 8-K26.0 KBVICURON PHARMACEUTICALS INCJun 6, 1:49 PM ET·0001193125-05-120678
- 8-K94.8 KBVICURON PHARMACEUTICALS INCMay 26, 11:55 AM ET·0001193125-05-115440
- 420.1 KBVICURON PHARMACEUTICALS INCFeb 8, 8:15 PM ET·0001181431-05-007963
- 8-K55.5 KBVICURON PHARMACEUTICALS INCFeb 7, 7:04 AM ET·0001193125-05-020265
- 10-Q502.4 KBVICURON PHARMACEUTICALS INCNov 8, 2:02 PM ET·0001193125-04-189183
- 8-K33.9 KBVICURON PHARMACEUTICALS INCSep 24, 5:12 PM ET·0001193125-04-161601
Insiders
10- AMBROSIO COSTANTINODirector, Chief Manufacturing Officer
- CAVANAUGH JAMES HDirector
- DUNTON ALAN WDirector
- GOLDSTEIN DOV A MDChief Financial Officer
- HENKEL TIMOTHY J MDChief Medical Officer
- HORNER GEORGE F IIIDirector, President & CEO
- MOSCONI GIORGIOSenior VP Business Development
- STOGNIEW MARTINExecutive Vice President
- WALSH CHRISTOPHER T PHDDirector
- WENZINGER CHERYLDirector
Tickers
No tickers on record
Addresses
business
455 SOUTH GULPH ROAD SUITE 305
KING OF PRUSSIA, PA, 19406
mailing
455 SOUTH GULPH ROAD SUITE 305
KING OF PRUSSIA, PA, 19406
Former Names
- VERSICOR INC /CA2003-03-17